Cholangiocarcinoma (CCA) is a very aggressive and lethal tumor, which arises from the epithelial cells of bile ducts. CCA comprises about 3% of all gastrointestinal malignancies and its incidence is on the rise in the recent years. Anatomically, it is classified into intrahepatic, perihilar, or extrahepatic (distal) CCA. There are a number of risk factors associated with CCA including primary sclerosing cholangitis, fibropolycystic liver disease, parasitic infection, viral hepatitis, chronic liver disease, and genetic disorders like Lynch syndrome. Autoimmune hepatitis is also recently reported to have an association with development of CCA. We report an interesting case of perihilar CCA in the setting of autoimmune hepatitis along with a l...
Cholangiocarcinoma has a worldwide distribution which accounts for about 10-15% of all cases of prim...
Objectives. Cirrhosis is a well-known risk factor for hepatocellular cancer, but the true risk in au...
BackgroundAutoimmune diseases are associated with many cancers but there is a lack of population-bas...
Hepatocellular carcinoma (HCC), the dominant primary malignancy of the liver, has almost invariably ...
The development of a primary hepatic tumor associated with autoimmune hepatitis (AIH) has been rarel...
Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system, which can be...
International audienceCholangiocarcinoma (CCA) results from the malignant transformation of cholangi...
Abstract Background Hepatocellular carcinoma (HCC) is a primary tumor of the liver. The majority of ...
Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer that arises from intrah...
Cholangiocarcinoma (CCA) results from the malignant transformation of cholangiocytes. Primary sclero...
[[abstract]]Primary liver cancer is the sixth most common cancer and third most common cause of canc...
AbstractCholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within ...
BACKGROUND & AIMS: Some autoimmune diseases are associated with increased risk of liver cancer. Howe...
Background/Aims: Autoimmune Hepatitis (AIH) is a liver disease which may lead to liver cirrhosis. Ci...
Hepatocellular carcinoma (HCC) typically originates from HBV or HCV associated liver cirrhosis. Prim...
Cholangiocarcinoma has a worldwide distribution which accounts for about 10-15% of all cases of prim...
Objectives. Cirrhosis is a well-known risk factor for hepatocellular cancer, but the true risk in au...
BackgroundAutoimmune diseases are associated with many cancers but there is a lack of population-bas...
Hepatocellular carcinoma (HCC), the dominant primary malignancy of the liver, has almost invariably ...
The development of a primary hepatic tumor associated with autoimmune hepatitis (AIH) has been rarel...
Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system, which can be...
International audienceCholangiocarcinoma (CCA) results from the malignant transformation of cholangi...
Abstract Background Hepatocellular carcinoma (HCC) is a primary tumor of the liver. The majority of ...
Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer that arises from intrah...
Cholangiocarcinoma (CCA) results from the malignant transformation of cholangiocytes. Primary sclero...
[[abstract]]Primary liver cancer is the sixth most common cancer and third most common cause of canc...
AbstractCholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within ...
BACKGROUND & AIMS: Some autoimmune diseases are associated with increased risk of liver cancer. Howe...
Background/Aims: Autoimmune Hepatitis (AIH) is a liver disease which may lead to liver cirrhosis. Ci...
Hepatocellular carcinoma (HCC) typically originates from HBV or HCV associated liver cirrhosis. Prim...
Cholangiocarcinoma has a worldwide distribution which accounts for about 10-15% of all cases of prim...
Objectives. Cirrhosis is a well-known risk factor for hepatocellular cancer, but the true risk in au...
BackgroundAutoimmune diseases are associated with many cancers but there is a lack of population-bas...